National Microbiology Framework - Lot 2: Research and Development Goods and Services

Public Health EnglandcontractContracts FinderRef tender_241726/956085SME suitablecomplete
View buyer

Estimated value

£1.5bn

Awarded value

£1.5bn

Awarded 12 Mar 2021

Suppliers

1

Lots

1

1 awarded

Published

23 Apr 2021

Deadline 14 Dec 2020

Description

Lot 2 is for the supply of goods and/or services for the qualitative/quantitative examination of specimens/samples and the development of assays/kits/medical or therapeutic products. This Lot consists of goods and services mainly for research and development, experimentation and study therefore CE marked (or UKCA marked) is not mandatory. This Lot includes provisions for reagent rental and managed equipment services. Please note that this Award Notice is for Lot 2, however the Framework Agreement encompasses the following four lots: - Lot 1: Diagnostic Goods and Services - Lot 2: Research and Development Goods and Services - Lot 3: Manufacturing, Product Development and Commercialisation - Lot 4: Clinical Laboratory Diagnostic Testing Services

Scope

Reference
tender_241726/956085
Total value
£1,500,000,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
22 Apr 2021 to 21 Apr 2023
CPV classifications
33000000 33100000 33124100
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
14 Dec 2020, 5:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£1.5bn

Award date

12 Mar 2021

Contract start

22 Apr 2021

Contract end

21 Apr 2023

Awarded to
M2
Mornington 2000 LLP trading as Sterilab Services,A.Menarini Diagnostics Ltd,Abcam Plc,Acarrier Limited,Agena Bioscience GmbH,Appleton Woods Ltd,AusDiagnostics UK Ltd,Abbott Rapid Diagnostics Limited,Becton, Dickinson U.K. Limited,BGI Genomics UK CO LTD,BioConnections Ltd,Bio-Rad Laboratories Limited,Bioserv UK Limited,BioSpyder Technologies, Inc.,Bio-Techne Ltd,Cambridge Bioscience Limited,Cambridge Life Sciences Limited,Clent Life Science,Don Whitley Scientific Ltd,Euroimmun UK Ltd,Fisher Scientific UK Limited,Fujirebio Europe,GeneFirst Limited,Greiner Bio-One Ltd,Hamilton Sales and Service UK Ltd,Healthlinked Ltd,Hologic Limited,Illumina Cambridge Ltd,Immensa Health Clinic Ltd,Eurofins Biomnis UK Ltd,Intertek Testing & Certification Ltd,LGC Genomics Limited,Life Technologies Limited,Luminex Corporation,Malvern Medical Developments Ltd,MGI International Sales Co. Ltd,Microbial Genomics Ltd (Trading as MicrobesNG),Natural History Museum Trading Company Ltd,New England Biolabs UK Ltd,Oxford Biosystems Ltd,Oxford Immunotec Ltd,Oxford Nanopore Diagnostics Ltd,PCR Biosystems Ltd,PerkinElmer LAS (UK) Limited,ProMake Ltd,Promega UK Ltd,Europlaz Technologies Ltd,Qiagen Ltd,Quanterix Corporation,QuantuMDx Group Limited,Randox Laboratories Ltd,Roche Diagnostics Limited,Sarstedt Ltd,Scientific Laboratory Supplies Ltd,Siemens Healthcare Diagnostics Ltd,Stratech Scientific Ltd,Sysmex UK Ltd,Tecan UK,Techno-path Distribution Ltd,Teva UK Ltd,Thermo Electron Manufacturing Ltd T/A Thermo Fisher Scientific,Thermo Fisher Diagnostics Ltd,Sterilin Ltd,Una Health Ltd,V. H. Bio Limited,VWR International Ltd,Wolf Laboratories Limited,Yourgene Health UK Limited,Yourgene Health UK Limited